Comparative Analysis of Real-World Acute Prescription Migraine Therapy Outcomes: Insights from the HeAD-US Study.

Teichrow D, Khorsand B, Fanning KM, Urani A, Cadiou F, Lipton RB, Ezzati A

DOI: 10.1101/2025.09.18.25336093
Published: 2025 Sep 19
Container: medRxiv : the preprint server for health sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1101/2025.09.18.25336093,
  title = {Comparative Analysis of Real-World Acute Prescription Migraine Therapy Outcomes: Insights from the HeAD-US Study.},
  author = {Teichrow D and Khorsand B and Fanning KM and Urani A and Cadiou F and Lipton RB and Ezzati A},
  year = {2025},
  journal = {medRxiv : the preprint server for health sciences},
  doi = {10.1101/2025.09.18.25336093},
  url = {https://doi.org/10.1101/2025.09.18.25336093}
}

RIS

TY  - JOUR
TI  - Comparative Analysis of Real-World Acute Prescription Migraine Therapy Outcomes: Insights from the HeAD-US Study.
AU  - Teichrow D
AU  - Khorsand B
AU  - Fanning KM
AU  - Urani A
AU  - Cadiou F
AU  - Lipton RB
AU  - Ezzati A
PY  - 2025
JO  - medRxiv : the preprint server for health sciences
DO  - 10.1101/2025.09.18.25336093
UR  - https://doi.org/10.1101/2025.09.18.25336093
ER  -

APA

D, T., B, K., KM, F., A, U., F, C., RB, L., & A, E. (2025). Comparative Analysis of Real-World Acute Prescription Migraine Therapy Outcomes: Insights from the HeAD-US Study.. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.09.18.25336093

Source records

pubmed · retrieved 2026-09-25T20:56:35.441Z